Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's WhyZacks Investment Research • 04/24/24
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 04/19/24
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 04/17/24
Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 04/10/24
Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)Seeking Alpha • 04/03/24
Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's WhyZacks Investment Research • 03/20/24
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a BetZacks Investment Research • 03/18/24
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?Zacks Investment Research • 03/18/24
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®GlobeNewsWire • 03/11/24
Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should KnowZacks Investment Research • 03/05/24
ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceGlobeNewsWire • 03/05/24
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 03/04/24
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 28.36%: Here's is How to TradeZacks Investment Research • 03/01/24
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?Zacks Investment Research • 03/01/24
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 02/28/24
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024GlobeNewsWire • 02/21/24
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsGlobeNewsWire • 02/21/24